Ad Code

PPQ Protocol: Step-by-Step Pharmaceutical Guide

Web of Pharma · Process Validation · GMP Manufacturing

PPQ Protocol: Step-by-Step Pharmaceutical Guide

A practical, audit-ready guide to writing, approving, executing, and reporting a Process Performance Qualification protocol for commercial pharmaceutical manufacture.

Protocol design Commercial batch strategy Sampling and acceptance criteria Audit-ready evidence
Quick
answer

A PPQ protocol is the pre-approved, controlled plan that defines how a commercial pharmaceutical process will be challenged, sampled, tested, documented, and judged. It states the objective, scope, responsibilities, prerequisites, batch strategy, critical quality attributes (CQAs), critical process parameters (CPPs), acceptance criteria, statistical review, deviation rules, reporting, and final approval decision.

PlanTranslate process knowledge and risk into a controlled qualification protocol.
ExecuteRun representative commercial batches with defined sampling and data controls.
DecideCompare objective evidence with criteria approved before execution.
SustainHand the validated process into continued process verification and change control.

A PPQ protocol turns a broad validation objective into an executable study. It tells operators what to do, tells samplers where and when to collect evidence, tells laboratories what to test, and tells reviewers how to decide whether the process is capable. The protocol must represent the process that will actually be used for routine manufacture—not a simplified demonstration that cannot be reproduced at commercial scale.

Good PPQ planning connects development knowledge, scale-up learning, equipment qualification, analytical readiness, material controls, operator training, and the quality system. It also anticipates what can go wrong. A well-written protocol makes room for deviations, OOS/OOT results, unexpected process events, data-integrity questions, and approved changes without allowing the team to move acceptance criteria after seeing the results.

This guide focuses on the protocol itself and complements the wider Process Validation in Pharmaceuticals lifecycle. The approach is designed for validation, QA, production, QC, engineering, technical operations, statistics, regulatory, and manufacturing science teams working within cGMP expectations.

What Is a PPQ Protocol?

A Process Performance Qualification (PPQ) protocol is a controlled document approved before execution that describes how a defined commercial process will be qualified. It converts the process control strategy into a study design and identifies the evidence required to support a lifecycle decision.

The protocol normally covers the product, site, batch size, equipment train, materials, process steps, operating ranges, CQAs, CPPs, in-process controls, sampling locations, laboratory methods, acceptance criteria, statistical tools, data-integrity controls, deviation handling, report requirements, and approval responsibilities.

PPQ is not the same as equipment PQ. Equipment Performance Qualification demonstrates that an individual system can perform its intended function. Process Performance Qualification evaluates the integrated manufacturing process—equipment, materials, people, methods, environment, controls, and product outcomes together.

Protocol, batch record, and report: the difference

DocumentMain purposeWhen it is used
PPQ protocolDefines the approved study design, evidence, criteria, responsibilities, and decision rules.Before and during PPQ execution.
PPQ batch record or execution attachmentCaptures actual manufacturing steps, settings, observations, samples, signatures, and contemporaneous data.During each qualification batch.
PPQ reportAnalyzes the completed evidence, deviations, trends, limitations, and lifecycle conclusion.After the required batches and data reviews are complete.

PPQ Protocol Readiness Gate

Do not start a PPQ batch simply because a protocol has been signed. The protocol should include a readiness gate that confirms the process, facility, equipment, people, materials, methods, and quality systems are ready to generate meaningful evidence. Any open item should have a documented impact assessment and an approved path forward.

Requirements and design

Confirm the intended use, process boundaries, product requirements, risk controls, and the approved URS or equivalent requirements are clear.

Qualification status

Verify that relevant design, installation, operational, and equipment performance evidence is approved or formally justified: DQ, IQ, OQ, and PQ.

Materials and suppliers

Check approved specifications, supplier status, incoming testing, storage, material identity, lot traceability, and any planned lot-to-lot variability.

Methods and laboratories

Confirm analytical procedures, instruments, reference standards, analysts, sample handling, laboratory capacity, and data review are ready for the planned workload.

Documents and training

Verify master batch records, SOP, logbooks, forms, line-clearance instructions, and role-based training are effective.

Open quality signals

Assess deviations, OOS/OOT results, complaints, changes, CAPA, maintenance, calibration, environmental events, and prior validation limits for PPQ impact.

Pre-execution checklist

  • Protocol revision, attachments, approvals, and effective date are controlled before the first batch.
  • Commercial equipment, utilities, instruments, automation, and environmental controls are available and within status.
  • Cleaning status, line clearance, calibration, preventive maintenance, and alarm checks are acceptable.
  • Materials and packaging components are released, identified, within expiry, and traceable to planned lots.
  • Manufacturing and laboratory personnel are trained on the protocol, sampling, recording, and escalation rules.
  • Sampling supplies, labels, containers, storage conditions, chain of custody, and laboratory capacity are confirmed.
  • All acceptance criteria and statistical methods are approved before results are generated.
  • Quality, production, QC, validation, engineering, and technical reviewers understand their decision rights.

PPQ Protocol: 12-Step Workflow

Use the following workflow as the backbone of a process-specific protocol. Each step should point to an attachment, data source, responsible role, and approval or decision point.

01

Define the objective

State the exact process-capability question and the quality decision the PPQ will support.

02

Set the scope

Identify product, strength, site, line, equipment, batch size, unit operations, packaging, and exclusions.

03

Assign roles

Define who executes, samples, tests, reviews, investigates, approves, and owns each open action.

04

Gather knowledge

Use development, scale-up, transfer, engineering, historical, supplier, and platform evidence.

05

Confirm readiness

Pass the documented gate for facilities, equipment, methods, materials, documents, people, and systems.

06

Choose batch strategy

Justify count, sequence, scale, lots, strengths, bracketing, matrixing, and enhanced monitoring.

07

Map CQAs and CPPs

Link material attributes and process parameters to product outcomes and control points.

08

Design sampling

Define location, timing, quantity, sample identity, handling, test, method, and data review.

09

Set criteria

Predefine limits for CQAs, CPPs, IPCs, yield, reconciliation, methods, deviations, and data quality.

10

Define execution

Describe the sequence, hold points, observations, interventions, recording rules, and stop or escalation triggers.

11

Manage events

State how deviations, OOS/OOT results, changes, missing data, invalid tests, and protocol amendments are handled.

12

Report and hand off

Specify analysis, report approval, final decision, open actions, CPV metrics, and routine-monitoring ownership.

PPQ Protocol Template: Required Sections

A protocol template is useful only when it prompts process-specific decisions. The table below can be adapted into a controlled document, electronic workflow, or validation-management system.

SectionWhat to includeReviewer question
Document controlTitle, document number, product, site, revision, effective date, authors, approvers, attachments, and change history.Is the approved version identifiable and protected from uncontrolled use?
Objective and rationalePurpose of PPQ, process-capability question, lifecycle stage, regulatory or internal trigger, and intended decision.Does the protocol answer a defined business and quality question?
Scope and exclusionsProducts, strengths, batch sizes, lines, unit operations, packaging, sites, and justified exclusions.Does the scope match the process that will be routinely manufactured?
ResponsibilitiesProduction, QA, QC, validation, engineering, warehouse, statistics, technical operations, and approval roles.Who owns each action, review, escalation, and final conclusion?
Process descriptionFlow diagram, equipment train, utilities, material inputs, operating ranges, hold times, interventions, and critical steps.Can a trained reader understand the process and its control points?
CQA, CPP, and material mapLink critical product attributes to parameters, material attributes, IPCs, alarms, sampling, and control strategy.Is every critical outcome connected to evidence in the study?
PrerequisitesQualification, calibration, cleaning, analytical readiness, supplier status, training, documents, utilities, and system checks.Could an unresolved prerequisite invalidate or limit the evidence?
Batch strategyNumber, sequence, scale, lots, strengths, equipment, bracketing, matrixing, and rationale for representativeness.Will the batches challenge relevant sources of variability?
Sampling and testingLocations, timing, sample quantity, tests, method references, sample handling, laboratories, and chain of custody.Can the plan detect expected variability and high-risk failure modes?
Acceptance criteriaPredefined CQA, CPP, IPC, yield, reconciliation, laboratory, equipment, data-integrity, and deviation criteria.Are the limits measurable, justified, and approved before execution?
Statistics and data reviewTrend plots, capability or tolerance approach, replicate handling, outlier rules, missing data, and review responsibilities.Will the analysis distinguish normal variation from a meaningful signal?
Event managementDeviation, OOS/OOT, change, protocol amendment, invalid test, investigation, impact assessment, and escalation.Can unexpected events be handled without weakening the study?
Report and approvalResults, raw-data reconciliation, deviations, limitations, conclusion, open actions, CPV handoff, and final signatures.What evidence is required to approve, restrict, repeat, or extend PPQ?

Batch Strategy: How Many PPQ Batches?

There is no universal batch number that automatically proves process validation. Three consecutive commercial-scale batches are a familiar convention, but the protocol should justify the number using process knowledge, risk, variability, scale, product complexity, transfer history, equipment differences, and the consequences of failure. A fixed number is not a substitute for a scientifically defensible evidence plan.

The planned batches should represent routine manufacture. If development or engineering batches are used to support the strategy, explain their relevance, differences, and bridging evidence. If a process includes multiple strengths, sizes, lines, or sites, use a documented bracketing or matrixing rationale only when the process and risks are sufficiently comparable.

Commercial scale

Use the intended equipment train and batch size whenever practical. Explain any scale differences and the evidence that bridges them.

Representative materials

Plan material lots, suppliers, grades, and attributes that reflect routine variability rather than idealized inputs.

Worst-case challenge

Include justified high-risk operating ranges, difficult-to-process strengths, longest holds, or challenging equipment configurations.

Bracketing and matrixing

Use only when scientific similarity, risk assessment, and documented rationale support combining evidence across conditions.

Enhanced monitoring

Increase sampling or trending where uncertainty is higher, then define when the process can move to routine monitoring.

Contingency plan

Define what happens if a batch is interrupted, rejected, repeated, or affected by an event that limits interpretability.

Practical rule: decide the evidence needed before selecting the batch count. The question is not “How do we reach three batches?” but “What evidence demonstrates reproducibility for this specific process and risk profile?”

PPQ Sampling and Testing Plan

Sampling should be designed to see variability, not merely to collect convenient end-product samples. The protocol should explain why each sample exists, how it relates to a risk or control, and how the result will influence the PPQ decision.

Sampling dimensionProtocol detailsExample purpose
Process step and timeDefine the operation, batch phase, beginning/middle/end point, hold point, or intervention that triggers collection.Detect mixing progression, drying endpoint, filling drift, or hold-time impact.
Location and patternIdentify equipment locations, spatial positions, lines, containers, units, or stratified sampling points.Detect segregation, temperature gradients, dead legs, or line-to-line differences.
Sample quantityState quantity, replicates, reserve samples, containers, labeling, storage, and maximum hold before testing.Support the method, statistical plan, investigations, and retesting rules.
Test and methodReference analytical method, in-process test, microbiological test, identity, assay, impurities, physical attribute, or appearance check.Link the measurement directly to a CQA, CPP, IPC, or material attribute.
ResponsibilityIdentify sampler, checker, laboratory, reviewer, and chain-of-custody owner.Maintain traceability from batch step to final result.
Data treatmentDefine averaging, individual results, replicate rules, invalid tests, missing samples, outliers, and trend displays.Prevent inconsistent interpretation after results are known.

Sampling controls to place in the protocol

  • Sample identifiers connect product, batch, step, location, date/time, sampler, container, and test request.
  • Sample containers, labels, storage, transport, and hold times protect the sample from mix-up or degradation.
  • Sampling equipment and instruments are clean, calibrated, suitable, and qualified for the intended use.
  • The plan distinguishes routine IPC samples, PPQ-only samples, reserve samples, and investigation samples.
  • Laboratory results are reviewed against the approved method and the protocol's individual-result criteria.
  • Any missed, compromised, or delayed sample is documented and assessed; it is not silently replaced.

Acceptance Criteria and Statistical Plan

Acceptance criteria must be measurable, scientifically justified, and approved before execution. They should distinguish product requirements from process-performance evidence. A finished-product specification alone may not demonstrate that the process is controlled throughout its operating space.

Critical quality attributes

Define limits for assay, content uniformity, dissolution, impurities, sterility or bioburden, physical attributes, fill volume, or other product-specific outcomes.

Critical process parameters

Set acceptable operating ranges or action limits for parameters that can affect CQAs, including temperature, time, speed, pressure, flow, or setpoint control.

In-process controls

Include blend uniformity, moisture, weight, torque, appearance, pH, viscosity, environmental conditions, or other real-time controls.

Yield and reconciliation

Define expected yield, material balance, line losses, rejects, rework, scrap, and documentation requirements for unexplained differences.

Capability and trends

Use capability indices, control charts, tolerance intervals, confidence bounds, or descriptive trends where appropriate to the data and risk.

Data quality

Include complete raw data, audit-trail review where applicable, method validity, sample traceability, calculations, and review of invalid or missing results.

Statistical tools should answer a defined question. For example, capability analysis can assess whether a stable process fits within a specification, while a trend chart can reveal drift across batches or within a batch. The protocol should explain how non-normal data, small sample sizes, autocorrelation, outliers, and missing values will be handled. Do not choose a statistical test merely because it is familiar.

Predefine the decision logic: state what happens when a result meets the product specification but misses a process criterion, when a trend is concerning but no limit is exceeded, or when an event limits the interpretability of a batch.

Execution-Day Controls for a PPQ Batch

Execution should follow the approved protocol and the routine batch record. Any difference between planned and actual execution should be visible, traceable, and assessed. Data should be recorded as the work happens in a way that follows ALCOA+ expectations and applicable electronic-record controls such as 21 CFR requirements.

01

Pre-start check

Verify status labels, line clearance, equipment, utilities, materials, instruments, documents, and trained personnel.

02

Team briefing

Review the protocol, sampling map, recording rules, escalation contacts, and stop criteria with everyone involved.

03

Execute and observe

Follow the approved process; record actual settings, adjustments, alarms, interventions, holds, and observations.

04

Sample and label

Collect the planned samples at the planned points and maintain identity, storage, chain of custody, and test requests.

05

Review in real time

Use second-person checks and QA oversight to catch omissions, transcription errors, unusual trends, and unplanned events.

06

Close the batch

Reconcile materials, review records, secure raw data, log events, and confirm that the batch package is complete.

07

Hold the decision

Do not declare success based on a preliminary result; complete laboratory, QA, deviation, and data reviews first.

08

Preserve evidence

Retain records, electronic data, audit trails, calculations, images, samples, and approvals according to the record-retention plan.

Deviation, OOS/OOT, and Change Handling

A PPQ protocol must not assume that every batch will be uneventful. It should define how events are documented, contained, investigated, and assessed for their effect on the validation conclusion. A deviation is not automatically a PPQ failure, and a specification result is not automatically proof that the process remains acceptable.

Signal or eventImmediate questionRequired protocol response
Unplanned process adjustmentWas the adjustment within the approved range and routine procedure?Record the actual condition, reason, authorization, product impact, and whether the batch remains representative.
CPP excursion or alarmDid the parameter exceed an acceptance limit or create a CQA risk?Contain, document, investigate, evaluate affected material and evidence, and escalate according to the decision tree.
OOS laboratory resultIs there a scientifically supported assignable cause or does the result represent the batch?Follow the approved OOS procedure; do not invalidate or retest merely to obtain a passing result.
OOT or adverse trendDoes the result signal drift even though the specification is met?Trend, assess process capability and risk, and determine whether additional monitoring or investigation is needed.
Missing or compromised sampleCan the planned conclusion still be supported without the sample?Document the reason, assess impact, avoid silent replacement, and define justified additional work if necessary.
Protocol change requestDoes the change preserve the original study objective and criteria?Use controlled amendment and QA approval before implementation unless an emergency action is required and documented.

When a PPQ event reveals a systemic issue, connect the investigation to the quality system. Use CAPA new when corrective or preventive action is needed, and document the relationship to the established CAPA process. A protocol should also explain when a change control, additional PPQ batch, requalification, or regulatory assessment is required.

PPQ Report and Approval Checklist

The PPQ report is the evidence-based conclusion of the study. It should make the decision understandable without forcing the reader to reconstruct the outcome from raw worksheets. A strong report explains what was planned, what actually happened, what the data show, what was excluded or limited, and why the final decision is justified.

Report sectionMinimum contentApproval check
Executive summaryProduct, batches, scope, major findings, deviations, limitations, and proposed conclusion.Can a decision-maker understand the result quickly and accurately?
Protocol compliancePlanned versus actual execution, protocol amendments, missed steps, and justified differences.Are differences transparent and assessed rather than hidden?
Batch and material reviewBatch identifiers, scale, equipment, material lots, suppliers, operators, dates, and relevant conditions.Were batches representative of routine manufacture?
Results and statisticsCQA, CPP, IPC, yield, reconciliation, laboratory, environmental, and trend results with appropriate analysis.Do the results support reproducibility and control?
Deviations and investigationsEvent summaries, root causes, impact assessments, CAPA, OOS/OOT outcomes, and open actions.Were all events assessed for their effect on the PPQ conclusion?
Conclusion and restrictionsValidated-state decision, conditions or restrictions, additional batches, enhanced monitoring, and CPV handoff.Is the conclusion proportional to the evidence and residual risk?
ApprovalsValidation, production, QC, QA, engineering, technical, regulatory, and site leadership signatures as applicable.Did authorized functions approve the decision and open actions?
  • All protocol batches, samples, tests, raw data, calculations, and attachments are accounted for.
  • Individual results, not only averages, are reviewed where the protocol requires them.
  • Any invalid test, retest, reinjection, missing record, or excluded result has a documented rationale.
  • Process capability and trend conclusions match the data type, sample size, and statistical assumptions.
  • Open deviations, CAPA, change controls, and additional monitoring have owners and due dates.
  • The report states whether routine manufacture is approved, restricted, repeated, or supported only with enhanced monitoring.
  • Stage 3 monitoring requirements are transferred to the owner of the continued process verification program.

Worked Example: Tablet PPQ Protocol

Consider an immediate-release tablet manufactured by dispensing, milling, blending, lubrication, compression, coating, and packaging. The protocol should not simply test three finished-product samples. It should connect each unit operation to the quality attributes that matter for dose delivery and product performance.

Blending and lubrication

Define blend sampling locations, mixing time, speed, material sequence, lubricant exposure, blend uniformity, and the risk of segregation during transfer.

Compression

Monitor turret speed, force, weight, thickness, hardness, friability, ejection behavior, compression defects, and beginning/middle/end samples.

Coating

Evaluate spray rate, inlet and exhaust conditions, pan speed, weight gain, appearance, moisture, adhesion, and the effect of interruptions or holds.

Finished product

Test identity, assay, content uniformity, dissolution, impurities, appearance, dimensions, packaging integrity, and any product-specific CQAs.

Decision evidence

Review individual and batch-level results, CPP trends, yields, deviations, material lots, laboratory data, and any restriction on routine operation.

CPV handoff

Transfer selected CQAs, CPPs, IPCs, control limits, and alert/action rules into the continued monitoring plan.

For this example, the PPQ report should explain whether the process is capable across the planned batches and whether the observed variability is consistent with the control strategy. A passing dissolution average alone would not address blend uniformity, compression drift, coating variability, or the data quality of the sampling process.

Common PPQ Protocol Mistakes

Copying a generic protocol

A template is used without updating equipment, risks, material attributes, process ranges, sampling, or product-specific CQAs.

Undefined decision

The protocol lists tests but never states what evidence is sufficient to approve, restrict, repeat, or extend PPQ.

Weak readiness gate

Open qualification, training, calibration, cleaning, method, or supplier issues are treated as administrative details.

Convenience batches

Batches are chosen because they are easy to schedule rather than because they represent commercial variability or risk.

Criteria changed after results

Limits, sample exclusions, or statistical methods are modified after seeing data without controlled scientific justification.

Weak sampling logic

Samples are collected only at the end of the batch, with no spatial, temporal, or critical-step rationale.

Incomplete raw data

Reports show summarized results but cannot trace them to original records, instrument files, calculations, or sample identities.

No CPV handoff

The study closes with a validation conclusion but does not transfer meaningful metrics, limits, owners, and review frequency to routine monitoring.

Audit-Ready PPQ Protocol Checklist

Use this condensed checklist during protocol authoring, QA review, or an internal readiness meeting.

  • Objective, scope, product, site, batch size, equipment train, and lifecycle stage are explicit.
  • Process knowledge and quality risk assessment are cited and translated into study controls.
  • CQAs, CPPs, material attributes, IPCs, and their relationships are clearly mapped.
  • Batch count, sequence, scale, material lots, strengths, bracketing, and matrixing are justified.
  • Prerequisites include DQ, IQ, OQ, equipment PQ, cleaning, calibration, methods, training, and approved documents.
  • Sampling locations, timing, quantities, replicates, handling, storage, and chain of custody are defined.
  • Tests, methods, laboratories, calculations, individual-result rules, and invalid-test handling are specified.
  • Acceptance criteria are approved before execution and include process, product, data, and event requirements.
  • Deviation, OOS/OOT, change, missing-data, and protocol-amendment decision trees are included.
  • Execution records follow ALCOA+ principles and applicable electronic-record requirements.
  • Report content, approval roles, open-action controls, restrictions, and CPV handoff are defined.
  • Every acceptance decision can be traced to an original record, calculation, result, or approved investigation.

Key Takeaways

Make it process-specific

A PPQ protocol should reflect the actual product, equipment, scale, materials, risks, and control strategy.

Approve criteria early

Acceptance limits, sample rules, and statistical methods must be settled before results are known.

Sample for variability

Use temporal, spatial, critical-step, material, and finished-product evidence to test the process—not just the final average.

Investigate fairly

Events, OOS/OOT results, missing samples, and excursions require documented impact assessment, not automatic exclusion.

Report the decision

The PPQ report should state what the evidence supports, what it does not support, and what restrictions or actions remain.

Connect to CPV

Transfer meaningful metrics, alert/action limits, ownership, and review frequency into routine continued verification.

Conclusion

A robust PPQ protocol is the operating blueprint for demonstrating that a pharmaceutical process can repeatedly produce acceptable product at its intended commercial scale. It combines process knowledge, risk-based planning, qualified systems, representative batches, scientifically designed sampling, predefined acceptance criteria, reliable data, and transparent investigation practices.

When the protocol is specific and executable, the PPQ study becomes more than a compliance exercise. It gives manufacturing and quality teams a defensible basis for routine production, a clear method for handling uncertainty, and a practical handoff into continued process verification. Review the final protocol with the same discipline applied to the process itself: every requirement should be traceable, every criterion should be justified, and every decision should be supported by complete evidence.

Related Pharmaceutical Quality Guides

Frequently Asked Questions

1. What is a PPQ protocol?

A PPQ protocol is a pre-approved controlled plan that defines how a commercial manufacturing process will be qualified. It describes scope, prerequisites, batch strategy, CQAs, CPPs, sampling, testing, acceptance criteria, deviations, data review, reporting, and the final decision.

2. Who approves a PPQ protocol?

Approval normally includes Quality Assurance and the functions responsible for validation, production, QC, engineering, technical operations, and regulatory commitments, as applicable to the site. The approval matrix should be defined by the pharmaceutical quality system.

3. What prerequisites should be complete before PPQ?

Relevant equipment, utilities, facilities, cleaning, instruments, computerized systems, analytical methods, materials, procedures, training, calibration, and quality records should be ready. Open items need a documented impact assessment and approved rationale.

4. How many batches are required for PPQ?

There is no universal number. Three consecutive commercial-scale batches are a common starting convention, but the protocol should justify the number using process knowledge, risk, variability, scale, product complexity, transfer history, and the evidence needed for the lifecycle decision.

5. What are CQAs and CPPs in a PPQ protocol?

Critical Quality Attributes are product properties that must remain within an appropriate range to assure quality. Critical Process Parameters are process variables whose variability can affect those attributes. The protocol links both to controls, sampling, and acceptance criteria.

6. What should a PPQ sampling plan include?

It should state the process step, timing, location, sample quantity, replicates, container, label, storage, chain of custody, test, method, laboratory, and data-treatment rules. Sampling should address temporal, spatial, material, and critical-step variability where relevant.

7. Can the protocol be changed after execution starts?

Only through controlled amendment or an approved procedure for an urgent event. The change must preserve the study objective, explain why it is needed, assess impact on already collected evidence, and be approved before implementation whenever practical.

8. How are deviations and OOS/OOT results handled?

They are documented and investigated under approved procedures, then assessed for impact on the batch and PPQ conclusion. Results should not be excluded or invalidated simply because they make the study less convenient. Additional work, CAPA, change control, or repeat batches may be required.

9. What is a PPQ report?

The PPQ report is the post-execution assessment of planned versus actual work, batch and laboratory results, statistics, deviations, data quality, limitations, open actions, and the final decision about process capability and routine manufacture.

10. How does a PPQ protocol connect to CPV?

PPQ identifies the CQAs, CPPs, trends, limits, and variability signals that should be monitored after qualification. The report should transfer those measures, owners, alert/action rules, and review frequency into the continued process verification program.